Pharmaceutical Packaging and Labeling Services for Military Shipment (MIL-STD-129 Compliance)

The contract requires full compliance with MIL-STD-129 and MIL-STD-2073-1E standards for the packaging, preservation, and labeling of Labetalol Hydrochloride Injection, ensuring all components meet rigorous military transportation and storage requirements. This includes secure, tamper-evident packaging methods, appropriate environmental preservation to maintain drug integrity, and precise labeling with barcodes, military identification codes, and handling instructions as mandated by the standards. Additionally, hazardous material labeling consistent with OSHA’s Hazard Communication Standard must be applied, clearly indicating the chemical nature, risks, and safety precautions for this injectable pharmaceutical product during transit and storage. The work is to be performed at Fort Stewart, Georgia, with a response deadline of August 3, 2026, and is classified as a subcontract under NAICS code 325998 for other pharmaceutical and medicinal product manufacturing. The contracting authority is the Department of Defense through the Medical Supply Chain Pharm FSA, indicating this is part of the military’s pharmaceutical supply chain logistics. Compliance with all technical, labeling, and safety specifications is non-negotiable, and failure to meet these standards could result in rejection of shipment, financial penalties, or contract termination. The requirement reflects a high-level operational need for reliable, standardized, and safe delivery of critical medications to military medical facilities.